Steroid Responsive Acute Inflammatory Demyelinating Polyneuropathy Induced by an Immune Check Point Inhibitor

Authors

  • Najwa Al-Bustani, MD Department of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, UAE https://orcid.org/0000-0001-6254-5899
  • Zulfiqar Hussain, MD Department of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, UAE

DOI:

https://doi.org/10.17161/rrnmf.v3i4.18080

Keywords:

Acute Inflammatory Demyelinating Polyneuropathy, nerve conduction study, intravenous immunoglobulin, steroids, immune check point inhibitors

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71(3):209-249.

Rihawi K, Gelsomino F, Sperandi F, et al. Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence. Ther Adv Respir Dis. 2017;11(9):353-373.

Zimmer L, Goldinger SM, Hofmann L, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. European Journal of Cancer. 2016;60:210-225.

Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. JCO. 2018;36(17):1714-1768.

de Maleissye MF, Nicolas G, Saiag P. Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy. N Engl J Med. 2016;375(3):296-297.

de Maleissye MF, Nicolas G, Saiag P. Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy. N Engl J Med. 2016;375(3):296-297.

Manam R, Martin JL, Gross JA, et al. Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy. Cureus. Published online September 27, 2018.

Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: A current review: CIPN. Ann Neurol. 2017;81(6):772-781.

Downloads

Published

2023-02-07

Issue

Section

Clinic and Case Reports

How to Cite

Al-Bustani, N., & Hussain, Z. (2023). Steroid Responsive Acute Inflammatory Demyelinating Polyneuropathy Induced by an Immune Check Point Inhibitor. RRNMF Neuromuscular Journal, 4(1), 32-33. https://doi.org/10.17161/rrnmf.v3i4.18080